Association of serum albumin and mortality risk

Journal of Clinical Epidemiology

Volumn 50, Issue 6, 1997, Pages 693-703

  Goldwasser, Philip ^a   Feldman, Joseph ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Mortality; Prognosis; Serum albumin

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CHRONIC DISEASE; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK; SERUM ALBUMIN;

EID: 0030843890     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00015-2     Document Type: Article

References (92)

1. 1. Alderman MH. Blood pressure management: Individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119: 329-335.
2. 2. Lowrie E, Lew N. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.
3. 3. United States Renal Data System. Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis 1992; 20(Suppl. 2): 32-38.
4. 4. Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ, Kasiske BL. Serum albumin and mortality after renal transplantation. Am J Kidney Dis 1996; 27: 117-123.
5. 5. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrell Jr FE. The APACHE III prognostic system - risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
6. 6. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2: 1434-1436.
7. 7. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J 1992; 123: 507-513.
8. 8. Klonoff-Cohen H, Barrett-Connor EL, Edelstein SL. Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol 1992; 45: 207-212.
9. 9. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994; 272: 1036-1042.
10. 10. Law MR, Morris JK, Wald NJ, Hale AK. Serum albumin and mortality in the BUPA study. Int J Epidemiol 1994; 23: 38-41.
11. 11. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP. The relation between serum albumin and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol 1991; 134: 1266-1277.
12. 12. Owen W, Lew NL, Liu Y, Lowrie EG, Lazarus J. The urea reduction ratio and serum albumin as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006.
13. 13. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994; 140: 876-878.
14. 14. Corti MC, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 1996; 49: 519-526.
15. 15. Kasiske BL, Guijarro C, Massy ZA, Wiedekehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165.
16. 16. Goldwasser P, Mittman N, Burrell D, Michel M-A, Collier J, Avram MM. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993; 3: 1613-1622.
17. 17. Rich MW, Keller AJ, Schechtman KB, Marshall WG Jr, Kouchoukos NT. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol 1989; 63: 714-718.
18. 18. Warnold I, Lundholm K. Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg 1984; 199: 299-305.
19. 19. Sullivan DH, Patch GA, Walls RC, Lipschitz DA. Impact of nutrition status on morbidity and mortality in a select population of geriatric rehabilitation patients. Am J Clin Nutr 1990; 51: 749-758.
20. 20. Rudman D, Feller AG, Nagraj HS, Jackson DL, Rudman IW, Mattson DE. Relation of serum albumin concentration to death rate in nursing home men. J Parent Enteral Nutr 1987; 11: 360-363.
21. 21. Sahyoun NR, Jacques PF, Dallal G, Russell RM. Use of albumin as a predictor of mortality in community-dwelling and institutionalized elderly populations. J Clin Epidemiol 1996; 49: 981-988.
22. 22. Burness R, Horne G, Purdie G. Albumin levels and mortality in patients with hip fractures. N Zeal Med J 1996; 109: 56-57.
23. 23. Emptage LA, Blackledge G. Association between serum albumin and mortality from prostate cancer. Lancet 1990; 1: 482. (Letter)
24. 24. Espinosa E, Feliu J, Zamora P, González Barón M, Sánchez JJ, Ordóñez A, Espinosa J. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer 1995; 12: 67-76.
25. 25. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular cancer in the United States. Cancer 1996; 77: 2217-2222.
26. 26. Fountzilas G, Kosmidis P, Beer M, Sridhar KS, Banis K, Vritsios A, Daniilidis J. Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. Ann Oncol 1992; 3: 553-558.
27. 27. Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Int Med 1992; 152: 125-130.
28. 28. Norman S-L T, Glickman ME, Sharma RGVRK, McNeil B. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. JAMA 1996; 275: 1322-1328.
29. 29. Shapiro S. Meta-analysis/Shmeta-analysis, Point/Counterpoint. Meta-analysis of Observational Studies. Am J Epidemiol 1994; 140: 771-778.
30. 30. Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K. Serum albumin concentration-related Health Care Financing Administration criterion is method-dependent: Revision is necessary. Am J Kidney Dis 1993; 21: 138-144.
31. 31. Torún B, Viteri FE. Protein-energy malnutrition. In: Shils ME, Young VR, Eds. Modern Nutrition in Health and Disease. 7th ed. Philadelphia, PA: Lea & Feibiger; 1988: 746:-773.
32. 32. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701.
33. 33. Lazarus JM. Nutrition in hemodialysis. Am J Kidney Dis 1993; 21: 99-105.
34. 34. Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 1994; 24: 912-920.
35. 35. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
36. 36. Pollak AJ, Strong RM, Gribbon R, Shah H. Lack of predictive value of the APACHE II score in hypoalbuminemic patients. J Parent Enteral Nutr 1991; 15: 313-315.
37. 37. Stevens RG Blumberg BS. Serum albumin and mortality. Lancet 1990; 335: 351. (Letter)
38. 38. Hulley SB, Newman TB. Cholesterol in the elderly. Is it important? J Am Med Soc 1994; 272: 1372-1374.
39. 39. Rothschild MA, Oratz M, Schreiber SS. Albumin synthesis. N Engl J Med 1972; 286: 748-757 (part 1) and 816-821 (part 2).
40. 40. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988; 8: 385-401.
41. 13C]leucine. Kidney Int 1992; 41: 132-138.
42. 42. Fleck A, Gaines G, Hawker F, Trotter J, Wallace PI, Ledingham IMcA, Calman KC. Increased vascular permeability: A major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 1: 781-784.
43. 43. Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchinson FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986; 29: 572-577.
44. 44. Pietrangelo A, Panduro A, Chowdhury JR, Shafritz DA. Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. J Clin Invest 1992; 89: 1755-1760.
45. 45. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995; 95: 39-45.
46. 46. Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, part III: Albumin and disease states. J Parent Enteral Nutr 1991; 15: 476-483.
47. 47. Bent-Hansen L. Whole body capillary exchange of albumin. Acta Phys Scand 1991; 143(Suppl. 603): 5-10.
48. 48. Jensen EW, Espersen K, Knudsen JH, Nielsen SL. Increased transcapillary escape rate in elderly subjects due to long-term smoking habits. Clin Phvsiol 1995; 15: 159-167.
49. 49. Brackeen GL. Serum albumin: Differences in assay specificity. Nutrition in Clinical Practice 1989; 6: 203-205.
50. 50. Gustafsson JEC. Improved specificity of serum albumin determination and estimation of acute phase reactants by use of the bromcresol green reaction. Clin Chem 1976; 22: 616-22.
51. 51. Speicher CE, Widish JR, Gaudot FJ, Hefler BR. An evaluation of the overestimation of serum albumin by bromcresol green. Am J Clin Path 1978; 69: 347-350.
52. 52. Koomen GCM, van Straalen JP, Boeschoten EW, Gorgels JPMC, Hoek FJ. Comparison between dye binding methods and nephelometry for the measurement of albumin in plasma of dialysis patients. Peritoneal Dial Int 1992; 12: 133. (Abstract)
53. 53. Wells FE, Addison GM, Postlethwaite PJ. Albumin analysis in serum of haemodialysis patients: Discrepancies between bromcresol purple, bromcresol green, and electroimmunoassay. Ann Clin Biochem 1985; 22: 304-309.
54. 54. Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978; 24: 80-86.
55. 55. Joseph R, Tria L, Mossey RT, Belluci AG, Mailloux LU, Vernace MA, Miller I, Wilkes BM. Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1996; 27: 566-572.
56. 56. Leerink CB, Winkers EKA. Multilayer-film bromcresol green method for albumin measurement is significantly inaccurate when albumin/globulin ratio is <0.8. Clin Chem 1991; 37: 766-767. (Letter)
57. 57. Geen RJ, Day BS, Powers DM. Clin Chem 1991; 37: 767-768. (Letter)
58. 58. Webster D, Bignell AHC, Attwood EC. An assessment of the suitability of bromcresol green for the determination of serum albumin. Clin Chem Acta 1974; 53: 101-108.
59. 59. Mabuchi H, Nakahashi H. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia. Clinica Chimica Acta 1987; 167:89-96.
60. 60. Maguire GA, Price CP. Bromcresol purple method for serum albumin gives falsely low values in patients with renal insufficiency. Clinica Chimica Acta 1986; 155: 83-88.
61. 61. Salive ME, Cornoni-Huntley J, Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM, Wallace RB. Serum albumin in older persons: Relationship with age and health status. J Clin Epidemiol 1992; 45: 213-221.
62. 62. Rall LC, Roubenoff R, Harris TB. Albumin as a marker of nutritional and health status. In: Rosenberg IH, Ed. Nutritional Assessment of Elderly Populations. Bristol-Myers Squib/Mead Johnson nutrition symposia. Vol. 13. New York: Raven Press; 1995: 40-49.
63. 63. Shimakawa T, Bild DE. Relationship between hemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol 1993; 46: 1257-1266.
64. 64. Goldwasser P, Michel M-A, Collier JC, Mittman N, Fein PA, Gusik S-A, Avram MM. Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 1993; 22: 215-225.
65. 65. Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: Relationships among them and to death. Semin Nephrol 1992; 12: 276-283.
66. 66. Ifudu O, Feldman J, Friedrnan EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-425.
67. 67. Yang C-S, Chen S-W, Chiang C-H, Wang M, Peng S-J, Kan Y-T. Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 1996; 27:380-386.
68. 68. Baumgartner R, Koehler K, Romero L, Garry PJ. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 1996; 64: 552-558.
69. 69. Huang Z, Himes JH, McGovern PG. Nutrition and subsequent hip fracture among a national cohort of white women. Am J Epidemiol 1996; 144: 124-134.
70. 70. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol 1993; 9: 317-343.
71. 71. Bellomo R. The cytokine network in the critically ill. Anaesthesia and Intensive Care 1992; 20: 288-302.
72. 72. Ballmer-Weber BK, Dummer R, Küng E, Burg G, Ballmer PE. Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool. Br J Cancer 1995; 71: 78-82.
73. 73. Grimble R. Serum albumin and mortality. Lancet 1990; 335: 350. (Letter)
74. 74. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
75. 75. Clinton SK, Libby P. Cytokines and growth-factors in atherogenesis. Arch Path Lab Med 1992; 116:1292-1300.
76. 76. Keany J Jr, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582-1589.
77. 77. Kaufmann MA, Castelli I, Pargger H, Drop LJ. Nitric oxide dose-response study in isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharm Exp Therapeutics 1995; 273: 855-862.
78. 78. Zoellner H, Höfler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockie S, Binder BR. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Science 1996; 109: 2571-2580.
79. 79. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 321: 1196-1197.
80. 80. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci 1993; 90: 7915-7922.
81. 81. Ferrari R. Oxygen free radicals at myocardial level: Effects of ischemia and reperfusion. Adv Exp Med Biol 1994; 366: 99-111.
82. 82. Halliwell B, Gutteridge MC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
83. 83. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995; 1247: 12-16.
84. 84. Cha M-K, Kim I-H. Glutathione-linked thiol peroxidase activity of human serum albumin: A possible role of serum albumin in blood plasma. Biochem Biophys Research Commun 1996; 222: 619-625.
85. 85. De Lorgeril M, Guidollet J, Renaud S. Serum albumin and mortality. Lancet 1990; 335: 349. (Letter)
86. 86. Williams WR, Pawlowicz A, Davies B. Serum albumin and mortality. Lancet 1990; 335: 349. (Letter)
87. 87. Sakai T, Takadate A, Otagiri M. Characterization of binding site of uremic toxins on human serum albumin. Biol Pharm Bull 1995; 18: 1755-1761.
88. 88. Refsum H, Helland S, Ueland PM. Radioenzymatic determination of homocysteine in plasma and urine. Clin Chem 1985; 31: 624-628.
89. 89. Porcellati S, Gresele P, Stasi M, Buratta S, Horrocks LA, De Fransceschi S, Nenchi GG, Goracci G. Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestering the liberated arachidonic acid in the extracellular space. Platelets 1995; 6: 381-387.
90. 90. Hill AB. The environment and disease. Association and causation. Proc Royal Soc Med 1965; 58: 295-300.
91. 91. Koretz RL. Intravenous albumin and nutrition support: Going for the quick fix. J Parent Enteral Nutr 1995; 19: 166-171.
92. 92. Wilmore DW. Catabolic illness: Strategies for enhancing recovery. N Engl J Med 1991; 325: 695-701.